A district court in Ohio Friday (Sept. 29) rejected a motion by the U.S. Chamber of Commerce to halt Medicare’s drug price negotiation program, dealing industry groups a defeat in the first of several cases aiming to block the program to come before a judge.
- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us